Increased NCOR1 and NCOR2/SMRT expression occurs also in breast and bladder cancer and suppressed the responsiveness of nuclear receptors that exert mitotic restraint, such as VDR and PPARα,γ [21,24,26,32,47–49,78]. Here, NCOR2 is linked to urinary bladder carcinoma.